OIP5 and neoplasm: In HBV-infected cells, OIP5-AS1 downregulation resulted in upregulation of HKDC1, which promotes glycolysis and accelerates cell cycle progression, thereby driving tumor growth and also it showed a reduction in expression in HBV-positive HCC patients.